Article thumbnail
Location of Repository

PDR temporal trends.

By Santiago Avila-Ríos (3219234), Claudia García-Morales (196309), Margarita Matías-Florentino (3219228), Daniela Tapia-Trejo (825189), Bismarck F. Hernández-Álvarez (3219222), Sumaya E. Moreira-López (3219231), Carlos J. Quant-Durán (3219237), Guillermo Porras-Cortés (3219225) and Gustavo Reyes-Terán (115886)


<p>PDR was estimated by year of enrolment using the HIVdb tool from Sanger sequences. Individuals with drug resistance were defined as those with at least low-level resistance (Stanford penalty score ≥15) to any drug of the corresponding class. A. PDR temporal trends by drug class. B. PDR temporal trends for the most widely used antiretroviral regimens in Nicaragua. C-E PDR temporal trends by drug, divided by drug class; only drugs currently used in clinical practice in the Nicaraguan context are shown. *p<0.05; linear regression, slope different to 0; the color corresponds to the significant category.</p

Topics: Medicine, Pharmacology, Biotechnology, Evolutionary Biology, Cancer, Science Policy, Infectious Diseases, Virology, Computational Biology, 41L, Protease inhibitor PDR, HIV pre-treatment drug resistance, first-line ART regimens, Stanford HIVdb tool, SDRM, HIV referral center, Roberto Calder ón Hospital, NNRTI PDR, 103N, baseline HIV genotyping, Largest Public Hospital, representative HIVDR surveillance studies, Nicaragua, NGS, CI, 2015. HIV pol sequences, surveillance drug resistance mutation, Results 283 individuals, HIV Drug Resistance
Year: 2016
DOI identifier: 10.1371/journal.pone.0164156.g004
OAI identifier:
Provided by: FigShare
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.